Skip to content

ZYNERBA PHARMACEUTICALS, INC.: 10-K filed 2019-03-11

What ZYNERBA PHARMACEUTICALS, INC. reported in its annual report filed 2019-03-11 (fiscal FY 2018): 36 published measures, 141 facts as tagged in accession 0001558370-19-001742.

This filing

Form
10-K (annual report)
Filed
2019-03-11
Fiscal period
fiscal FY 2018
Accession
0001558370-19-001742 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All ZYNERBA PHARMACEUTICALS, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2018-12-3167,327,443USD
At 2017-12-3169,054,309USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2018-12-319,725,782USD
At 2017-12-318,104,721USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2018-12-3157,601,661USD
At 2017-12-3160,949,588USD
At 2016-12-3129,587,308USD
At 2015-12-3139,705,924USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2018-12-3159,763,773USD
At 2017-12-3162,510,277USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2018-01-01 to 2018-12-31-39,911,175USD365
2017-01-01 to 2017-12-31-32,012,304USD365
2016-01-01 to 2016-12-31-23,388,507USD366

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2018-01-01 to 2018-12-31-32,397,351USD365
2017-01-01 to 2017-12-31-25,842,451USD365
2016-01-01 to 2016-12-31-20,438,166USD366

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2018-01-01 to 2018-12-31286,658USD365
2017-01-01 to 2017-12-31115,356USD365
2016-01-01 to 2016-12-31109,628USD366

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2018-10-01 to 2018-12-3186,000USD92
2018-01-01 to 2018-12-3186,000USD365
2017-01-01 to 2017-12-310USD365
2016-01-01 to 2016-12-317,250USD366

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2018-01-01 to 2018-12-3129,937,505USD365
2017-01-01 to 2017-12-3157,502,293USD365
2016-01-01 to 2016-12-3110,000,525USD366

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2018-01-01 to 2018-12-31-286,658USD365
2017-01-01 to 2017-12-31-115,356USD365
2016-01-01 to 2016-12-31-109,628USD366

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2018-12-31-117,892,041USD
At 2017-12-31-77,980,866USD

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2018-01-01 to 2018-12-310USD365
2017-01-01 to 2017-12-310USD365
2016-01-01 to 2016-12-31-27,543USD366

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2018-12-31371,963USD
At 2017-12-31164,527USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2018-01-01 to 2018-12-316,625,743USD365
2017-01-01 to 2017-12-315,646,852USD365
2016-01-01 to 2016-12-313,269,366USD366

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2018-10-01 to 2018-12-31-8,046,206USD92
2018-01-01 to 2018-12-31-40,397,830USD365
2018-07-01 to 2018-09-30-7,985,682USD92
2018-04-01 to 2018-06-30-11,969,806USD91
2018-01-01 to 2018-03-31-12,396,136USD90
2017-10-01 to 2017-12-31-8,204,504USD92
2017-01-01 to 2017-12-31-32,823,009USD365
2017-07-01 to 2017-09-30-8,549,603USD92
2017-04-01 to 2017-06-30-8,365,654USD91
2017-01-01 to 2017-03-31-7,703,248USD90
2016-01-01 to 2016-12-31-23,207,628USD366

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2018-12-3166,955,480USD
At 2017-12-3168,227,582USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2018-12-319,725,782USD
At 2017-12-317,442,721USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2018-12-314,461,567USD
At 2017-12-313,355,255USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2018-10-01 to 2018-12-318,132,206USD92
2018-01-01 to 2018-12-3140,483,830USD365
2018-07-01 to 2018-09-307,985,682USD92
2018-04-01 to 2018-06-3011,969,806USD91
2018-01-01 to 2018-03-3112,396,136USD90
2017-10-01 to 2017-12-318,204,504USD92
2017-01-01 to 2017-12-3132,823,009USD365
2017-07-01 to 2017-09-308,549,603USD92
2017-04-01 to 2017-06-308,365,654USD91
2017-01-01 to 2017-03-317,703,248USD90
2016-01-01 to 2016-12-3123,214,878USD366

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2018-10-01 to 2018-12-314,876,162USD92
2018-01-01 to 2018-12-3127,245,043USD365
2018-07-01 to 2018-09-304,859,902USD92
2018-04-01 to 2018-06-308,533,466USD91
2018-01-01 to 2018-03-318,975,513USD90
2017-10-01 to 2017-12-315,828,091USD92
2017-01-01 to 2017-12-3122,806,107USD365
2017-07-01 to 2017-09-305,753,764USD92
2017-04-01 to 2017-06-305,732,797USD91
2017-01-01 to 2017-03-315,491,455USD90
2016-01-01 to 2016-12-3116,784,626USD366

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2018-12-3117,626,873shares
At 2017-12-3113,553,873shares

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

PeriodValueUnitDays
At 2018-12-3159,763,773USD
At 2017-12-3162,510,277USD
At 2016-12-3130,965,791USD
At 2015-12-3141,513,060USD

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2018-12-31175,476,075USD
At 2017-12-31138,916,900USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2018-12-31634,623USD
At 2017-12-31327,615USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2018-12-31262,660USD
At 2017-12-31163,088USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2017-12-31662,200USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2018-12-315,264,215USD
At 2017-12-313,915,491USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2018-12-313,747,087USD
At 2017-12-311,733,701USD

Current contract liabilities

Consideration received before performance obligations are satisfied, often called deferred revenue. It is an obligation to deliver, not earned revenue or cash available.

PeriodValueUnitDays
At 2017-12-31171,975USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2018-01-01 to 2018-12-31-39,911,175USD365
2017-01-01 to 2017-12-31-32,012,304USD365
2016-01-01 to 2016-12-31-23,416,050USD366

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2018-01-01 to 2018-12-31-39,911,175USD365
2017-01-01 to 2017-12-31-32,012,304USD365
2016-01-01 to 2016-12-31-23,388,507USD366

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2018-10-01 to 2018-12-31-7,790,243USD92
2018-01-01 to 2018-12-31-39,911,175USD365
2018-07-01 to 2018-09-30-7,807,365USD92
2018-04-01 to 2018-06-30-12,007,233USD91
2018-01-01 to 2018-03-31-12,306,334USD90
2017-10-01 to 2017-12-31-8,118,599USD92
2017-01-01 to 2017-12-31-32,012,304USD365
2017-07-01 to 2017-09-30-8,311,205USD92
2017-04-01 to 2017-06-30-8,323,479USD91
2017-01-01 to 2017-03-31-7,259,021USD90
2016-01-01 to 2016-12-31-23,388,507USD366

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2018-10-01 to 2018-12-313,256,044USD92
2018-01-01 to 2018-12-3113,238,787USD365
2018-07-01 to 2018-09-303,125,780USD92
2018-04-01 to 2018-06-303,436,340USD91
2018-01-01 to 2018-03-313,420,623USD90
2017-10-01 to 2017-12-312,376,413USD92
2017-01-01 to 2017-12-3110,016,902USD365
2017-07-01 to 2017-09-302,795,839USD92
2017-04-01 to 2017-06-302,632,857USD91
2017-01-01 to 2017-03-312,211,793USD90
2016-01-01 to 2016-12-316,430,252USD366

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2018-01-01 to 2018-12-3199,572USD365
2017-01-01 to 2017-12-3194,211USD365
2016-01-01 to 2016-12-3175,301USD366

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2018-10-01 to 2018-12-31255,963USD92
2018-01-01 to 2018-12-31486,655USD365
2018-07-01 to 2018-09-30178,317USD92
2018-04-01 to 2018-06-30-37,427USD91
2018-01-01 to 2018-03-3189,802USD90
2017-10-01 to 2017-12-3185,905USD92
2017-01-01 to 2017-12-31810,705USD365
2017-07-01 to 2017-09-30238,398USD92
2017-04-01 to 2017-06-3042,175USD91
2017-01-01 to 2017-03-31444,227USD90
2016-01-01 to 2016-12-31-208,422USD366

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2018-01-01 to 2018-12-311,103,013USD365
2017-01-01 to 2017-12-311,492,171USD365
2016-01-01 to 2016-12-311,044,127USD366

Inspect the source

Entity
ZYNERBA PHARMACEUTICALS, INC. / CIK 0001621443
Captured
SEC response SHA-256
eb291da6063ca15bb79701a29894e4fddd9d66bcb1e18e0733be9f2efb07eaa3

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001621443.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))